Japan Sleep Apnea Device Market Size, Share, and COVID-19 Impact Analysis, By Product (Therapeutics, Diagnostics), By Application (Obstructive Sleep Apnea, Central Sleep Apnea, and Mixed Sleep Apnea), and Japan Sleep Apnea Device Market Insights, Industry Trend, Forecasts to 2035.

Industry: Healthcare

RELEASE DATE Jun 2025
REPORT ID SI12661
PAGES 234
REPORT FORMAT PathSoft

Japan Sleep Apnea Device Market Insights Forecasts to 2035

  • The Japan Sleep Apnea Device Market Size Was Estimated at USD 295.14 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 6.45% from 2025 to 2035
  • The Japan Sleep Apnea Device Market Size is Expected to Reach USD 587.27 Million by 2035

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights & Consulting, the Japan Sleep Apnea Device Market Size is anticipated to reach USD 587.27 Million by 2035, growing at a CAGR of 6.45% from 2025 to 2035. The market is driven by Japan’s aging population and the rising prevalence of sleep-related disorders, especially obstructive sleep apnea.

 

Market Overview

The Japan sleep apnea device market includes diagnostic and therapeutic equipment used to detect and treat sleep apnea, a condition where breathing repeatedly stops and starts during sleep.  The market for sleep apnea devices in Japan is also being driven by the trend toward home healthcare. There is a rising need for portable, easy-to-use sleep apnea devices that may be used outside of hospital settings as people seek to manage chronic diseases at home. This tendency is notably noticeable in Japan, where the healthcare system is putting more of an emphasis on encouraging home care for chronic illnesses, particularly among the elderly, and lowering hospital stays. For example, the use of medical devices that are used at home, such as sleep apnea equipment, has been steadily increasing, according to the Japan Home Healthcare Association. Because of its portability and simplicity of use, portable CPAP machines are becoming more and more popular, enabling patients to continue their treatment plans at home.

 

Report Coverage

This research report categorizes the market for the Japan sleep apnea device market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan sleep apnea device market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan sleep apnea device market.

 

Japan Sleep Apnea Device Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 295.14 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :6.45%
2035 Value Projection:USD 587.27 Million
Historical Data for:2020-2023
No. of Pages:234
Tables, Charts & Figures:110
Segments covered:By Product, By Application
Companies covered:: ResMed, Respironics (a subsidiary of Koninklijke Philips N.V.), Fisher & Paykel Healthcare Limited, BMC Medical Co., Ltd, Somnomed Limited, Compumedics Limited, Weinmann Medical Devices GmbH, and Others
Pitfalls & Challenges:COVID-19 Impact, Challenges, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The market for sleep apnea devices is primarily driven by the increasing prevalence of sleep apnea in Japan. Due in large part to the aging population and rising obesity rates, sleep apnea in particular, obstructive sleep apnea, or OSA—has become more prevalent. These variables have a substantial correlation with the development of sleep apnea, which can result in disturbed sleep patterns and associated health problems such diabetes, hypertension, and cardiovascular illnesses. The number of people with sleep apnea is increasing as the population ages, which raises the need for efficient diagnostic and therapeutic solutions. The market is expanding as a result of growing public and healthcare professional awareness of the serious health consequences associated with untreated sleep apnea.

 

Restraining Factors

Wearable monitoring and polysomnography systems are examples of advanced technology whose exorbitant costs prevent cost-conscious users from adopting them, despite their expansion. Treatment and diagnosis are delayed by cultural reluctance to participate in sleep tests and limited access in rural areas. Patients may also become discouraged by regulatory obstacles and the fact that some medicines are not covered by insurance. The market penetration of sleep apnea is further slowed by a lack of knowledge about its health implications.

 

Market Segmentation

The Japan sleep apnea device market share is classified into product and application.

 

  • The therapeutics segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan sleep apnea device market is segmented by product into therapeutics, diagnostics. Among these, the therapeutics segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to their proven effectiveness in treating obstructive sleep apnea, widespread clinical adoption, and technological advancements that have made them quieter, more compact, and user-friendly.

 

  • The obstructive sleep apnea segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan sleep apnea device market is segmented by application into obstructive sleep apnea, central sleep apnea, and mixed sleep apnea. Among these, the obstructive sleep apnea segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. In Japan, obstructive sleep apnea is the most common type, especially in older people and those who are obese or have other lifestyle-related disorders.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan sleep apnea device market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • ResMed
  • Respironics (a subsidiary of Koninklijke Philips N.V.)
  • Fisher & Paykel Healthcare Limited
  • BMC Medical Co., Ltd
  • Somnomed Limited
  • Compumedics Limited
  • Weinmann Medical Devices GmbH
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan Sleep Apnea Device Market based on the following segments:

 

Japan Sleep Apnea Device Market, By Product

  • Therapeutics
  • Diagnostics

 

Japan Sleep Apnea Device Market, By Application

  • Obstructive Sleep Apnea
  • Central Sleep Apnea
  • Mixed Sleep Apnea

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies